These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14020871)

  • 1. Experience with IDU.
    CHING RP
    Arch Ophthalmol; 1963 Apr; 69():543-4. PubMed ID: 14020871
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes simplex treatment with IDU and corticosteroids.
    KAUFMAN HE; MARTOLA EL; DOHLMAN CH
    Arch Ophthalmol; 1963 Apr; 69():468-72. PubMed ID: 14031372
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral substances: treatment of herpes simplex keratitis by 5-iodo-2'-deoxyuridine.
    BLATTNER RJ
    J Pediatr; 1962 Nov; 61():792-4. PubMed ID: 13971554
    [No Abstract]   [Full Text] [Related]  

  • 4. [MODERN TREATMENT OF HERPETIC KERATITIS].
    WILCZEK M; ZYGULSKA-MACHOWA H; WILCZEK Z
    Pol Tyg Lek; 1964 Jul; 19():1035-7. PubMed ID: 14190843
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of 1-beta-D-arabinofuranosylcytosine hydrochloride against herpes simplex keratitis.
    UNDERWOOD GE
    Proc Soc Exp Biol Med; 1962 Dec; 111():660-4. PubMed ID: 13995366
    [No Abstract]   [Full Text] [Related]  

  • 6. CYTOSINE ARABINOSIDE (CA) AND OTHER NUCLEOSIDES IN HERPES VIRUS INFECTIONS.
    UNDERWOOD GE; WISNER CA; WEED SD
    Arch Ophthalmol; 1964 Oct; 72():505-12. PubMed ID: 14191102
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the possibility of recurrence of herpetic keratitis treated with 5-iodo-2'-deoxyuridine (IDU)].
    PARDUCCI F; ZUCCHINI G
    Ann Ottalmol Clin Ocul; 1962 Oct; 88():448-52. PubMed ID: 13941386
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonism and toxicity of IDU by its degradation products.
    MALONEY ED; KAUFMAN JE
    Invest Ophthalmol; 1963 Feb; 2():55-7. PubMed ID: 13932626
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of specific antiviral agents in herpes simplex keratitis.
    KAUFMAN HE; MALONEY ED; NESBURN AB
    Invest Ophthalmol; 1962 Oct; 1():686-92. PubMed ID: 14031369
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
    Sundmacher R
    Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INHIBITION OF URIDINE RIBONUCLEOTIDE SYNTHESIS BY 5-HALOGENATED-2'-DEOXYURIDINE ANALOGUES.
    STONE JE
    Nature; 1964 Oct; 204():190-1. PubMed ID: 14222272
    [No Abstract]   [Full Text] [Related]  

  • 12. CORNEAL TOXICITY OF CYTOSINE ARABINOSIDE.
    KAUFMAN HE; CAPELLA JA; MALONEY ED; ROBBINS JE; COOPER GM; UOTILA MH
    Arch Ophthalmol; 1964 Oct; 72():535-40. PubMed ID: 14191107
    [No Abstract]   [Full Text] [Related]  

  • 13. [CHEMOTHERAPY OF VIRUS DISEASES].
    KITAMOTO O
    Sogo Rinsho; 1964 Jul; 13():1248-54. PubMed ID: 14176103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adverse side effects caused by topically applied antiviral agents in herpetic keratitis].
    Chen CW
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Aug; 5(8):416-29. PubMed ID: 2480457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of IDC and IDU on experimental herpetic keratitis].
    Nakamura T; Kobayashi S
    Nippon Ganka Gakkai Zasshi; 1964 May; 68(6):365-7. PubMed ID: 5892385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical resistance of herpetic keratitis to antiviral agents (author's transl)].
    Colin J; Chastel C; Baikoff G; Renard G
    J Fr Ophtalmol; 1981; 4(1):57-60. PubMed ID: 6260850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New trends in the treatment of herpetic corneal diseases].
    ZINTZ R; VIVELL O
    Ophthalmologica; 1963; 145():320-7. PubMed ID: 14003772
    [No Abstract]   [Full Text] [Related]  

  • 18. Ara-A and IDU therapy of human superficial herpetic keratitis.
    Laibson PR; Hyndiuk R; Krachmer JH; Schultz RO
    Invest Ophthalmol; 1975 Oct; 14(10):762-3. PubMed ID: 1102484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [TREATMENT OF HERPETIC KERATITIS].
    MALANOVA NL
    Vestn Oftalmol; 1963; 76():21-8. PubMed ID: 14094929
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
    Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
    Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.